Weight loss does not remove existing joint damage, but it can alter how much stress joints manage during routine movement, which may influence daily comfort
The location and severity of your Achilles injury influences the optimal BPC-157 protocol
Ethosuximide: valproate may increase ethosuximide concentrations and lead to toxicity
Complete our waitlist form to be notified when FOXO4-DRI becomes available
The Ro Body Program offers comprehensive weight loss management
Incretin-based therapies, specifically agonists of glucagon-like peptide-1 receptors (GLP-1 RAs) and glucose-dependent insulinotropic polypeptide (GIP) receptors, have demonstrated benefits for regulating appetite, improving glucose homeostasis, and reducing cardiovascular risk (2, 3)